Stay updated on Lenva+Pembro Combo in Cancers: Clinical Trial
Sign up to get notified when there's something new on the Lenva+Pembro Combo in Cancers: Clinical Trial page.

Latest updates to the Lenva+Pembro Combo in Cancers: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page no longer shows the 403 error or the NIH transition notice, and its main content area is blank while the site header and footer remain.SummaryDifference2%

- Check18 days agoChange DetectedThe page remains a 403 Forbidden error, with the displayed site revision changing from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The study page itself continues to show a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site footer’s revision number changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays Revision: v3.7.0, and several older items such as study documents and historical entries have been removed from the Study Documents section.SummaryDifference19%

Stay in the know with updates to Lenva+Pembro Combo in Cancers: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenva+Pembro Combo in Cancers: Clinical Trial page.